Mr. Sekhri has over 30 years of experience in the Life Science Industry. His experience encompasses senior management in large corporate pharmaceutical and biotechnology companies, as well as private equity and venture capital. Mr. Sekhri is President and Chief Executive Officer of vTv Therapeutics, Inc. Most recently he served as President and CEO of eGenesis, Inc. from 2019-2022 where he remains a Board Member and Senior Advisor to the Chairman. Prior to joining eGenesis, he was President and CEO of Lycera Corp. from 2015-2019. Prior to this, he served as Senior Vice President, Integrated Care for Sanofi from 2014-2015. Previously, he served as Chief Strategy Officer and Group Executive Vice President, Global Business Development for Teva Pharmaceutical Industries, Ltd. Prior to joining Teva, he spent five years as Operating Partner and Head of the Biotechnology Operating Group at TPG Biotech, the life sciences venture capital arm of TPG Capital. From 2004-2009, Mr. Sekhri was Founder, President, and Chief Executive Officer of Cerimon Pharmaceuticals, Inc. Prior to founding Cerimon, Mr. Sekhri was President and Chief Business Officer of ARIAD Pharmaceuticals, Inc. Previously, Mr. Sekhri spent five years at Novartis as Senior Vice President, and Head of Global Search and Evaluation, Business Development and Licensing for Novartis Pharma AG.

Mr. Sekhri has been a director on more than 30 private, public company, and non-profit Boards and is currently a member of the Board of Directors of Axcella Therapeutics, eGenesis, Inc., Ipsen, S.A., Likeminds, Longboard Pharmaceuticals, Oryn Therapeutics, Spring Discovery and Veeva Systems Inc. Mr. Sekhri is also the Chairman of the Board of Compugen Ltd. and Chairman of Board of Supervisory Directors of Pharming N.V. Additionally, he is on the Board of Directors of The Metropolitan Opera, The English Concert in America and was a member of the Board of Trustees of Carnegie Hall. He is Chairman of the Board of the Knights Ensemble, and most recently was nominated as Chairman of the Board of Trustees of Young Concert Artists, Inc.